@article{article, title  = {{Cost effectiveness of ranibizumab vs aflibercept vs bevacizumab for the treatment of macular oedema due to central retinal vein occlusion: the LEAVO study}},

 publisher = {{Springer}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/173442 }},

 year = {{2021}},

 month = {{8}},

 author = {{Pennington R and Alshreef A and Flight L and Metry A and Poku E and Hykin P and Sivaprasad S and Prevost AT and Vasconcelos JC and Murphy C and Kelly J et al}},

 doi = {{10.1007/s40273-021-01026-5}},

 volume = {{39}},

 journal = {{PharmacoEconomics}},

 issue = {{8}},

 pages = {{913-927}},

 note = {{Accessed on 2025/11/20}}}